Skip to main content
. 2014 Jul 14;6:145. doi: 10.3389/fnagi.2014.00145

Table 1.

Subject demographics at baseline.

N Gender M/F Age Years of education APOE e4 carriers
WHOLE AddNeuroMed DATASETa
AD 119 41/78 75.5 ± 6.0 8.0 ± 4.0 64 [54%]
CTL 110 50/60 73.0 ± 6.5 10.8 ± 4.8 31 [28%]
MCI 119
MCI-c 22 14/8 72.8 ± 6.4 9.2 ± 4.3 13 [59%]
MCI-nc 97 46/51 74.7 ± 5.4 8.8 ± 4.3 26 [27%]
AddNeuroMed LONGITUDINAL DATASETb
AD 62 16/46 74.0 ± 5.6 8.6 ± 4.0 34 [55%]
CTL 79 35/44 74.5 ± 5.5 10.3 ± 4.5 25 [32%]
MCI 73
MCI-c 13 8/5 71.8 ± 5.7 9.5 ± 4.3 8 [62%]
MCI-nc 60 30/30 75.7 ± 0.7 9.2 ± 4.4 15 [25%]

Data is presented as mean ± standard deviation. The longitudinal dataset consists of individuals followed longitudinally over 1-year and assessed using cognitive batteries and MRI scans. AD, Alzheimer disease; CTL, healthy control; MCI-c, MCI converters; MCI-nc, MCI non-converters; MCI, Mild cognitive impairment.

a

Significant differences in Age (AD vs. CTL Mann-Whitney test P = 0.002) and years of education (AD vs. CTL and MCI vs. CTL Mann-Whitney test P < 0.004).

b

Significant differences in Age (MCI-c vs. MCI-nc Mann-Whitney test P = 0.04), gender (AD vs. MCI Mann-Whitney test P = 0.009) and years of education (AD vs. CTL Mann-Whitney test P = 0.014).